+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bioanalytical Testing Services Market by Service Type (Biomarker Analysis, DMPK Services, Genetic Toxicology), Technology (GC-MS, HPLC, Immunoassays), Application, End User - Global Forecast 2025-2030- Product Image
Bioanalytical Testing Services Market by Service Type (Biomarker Analysis, DMPK Services, Genetic Toxicology), Technology (GC-MS, HPLC, Immunoassays), Application, End User - Global Forecast 2025-2030- Product Image
Sale

Bioanalytical Testing Services Market by Service Type (Biomarker Analysis, DMPK Services, Genetic Toxicology), Technology (GC-MS, HPLC, Immunoassays), Application, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011342
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Bioanalytical Testing Services Market grew from USD 4.74 billion in 2024 to USD 5.22 billion in 2025. It is expected to continue growing at a CAGR of 9.66%, reaching USD 8.25 billion by 2030.

Exploring the Fundamental Role of Bioanalytical Testing Services in Advancing Drug Development and Research Innovations Globally

Bioanalytical testing services have emerged as a cornerstone of modern drug development, providing critical data that inform every stage of pharmaceutical and biotechnology pipelines. Through precise evaluation of biomolecules, these services validate efficacy, monitor safety, and underpin regulatory submissions worldwide. As therapeutic modalities evolve, from small molecules to complex biologics, the demand for robust assays and high-throughput analytical platforms continues to rise.

In light of these dynamics, this executive summary synthesizes the prevalent trends shaping the industry, highlights key drivers, and offers a clear lens into emerging challenges. By outlining the current state of technologies, segmentation patterns, and regional nuances, stakeholders can pinpoint areas of innovation and efficiency gains. Ultimately, this introduction sets the stage for a comprehensive exploration of how bioanalytical testing is transforming research workflows and accelerating time to market.

Understanding the Transformative Technological and Regulatory Paradigms Reshaping Bioanalytical Testing Services

Over the past decade, the bioanalytical testing landscape has undergone transformative shifts driven by advancements in instrumentation, methodology, and regulatory frameworks. Cutting-edge mass spectrometry platforms paired with robotics and automated sample handling have dramatically reduced turnaround times, enabling laboratories to process larger sample volumes with greater accuracy. Concurrently, digitalization of data management through cloud-based solutions and artificial intelligence-powered analytics has ushered in a new era of operational efficiency and real-time decision support.

Regulatory expectations have also evolved, with agencies demanding more stringent validation protocols and adherence to data integrity standards. As a result, laboratories have embraced quality-by-design principles, embedding robust controls throughout assay development and execution. Cross-industry collaborations between pharmaceutical firms, contract research organizations, and academic institutions have further accelerated innovation, leading to more predictive toxicology models and multiplexed assay platforms. These collective trends underscore a seismic shift toward integrated, end-to-end bioanalytical ecosystems poised to deliver faster, more reliable insights.

Evaluating the Cumulative Supply Chain Impact of the 2025 United States Tariff Realignment on Bioanalytical Testing

The implementation of the updated United States tariff structure in 2025 has introduced added complexity to the global supply chain for bioanalytical testing consumables and instrumentation. Import duties on specialized reagents, solvents, and assay kits have translated into elevated procurement costs for both in-house and outsourced laboratory operations. In response, many organizations have sought strategic diversification of supplier networks, engaging regional manufacturers and distributors to mitigate exposure to tariff-induced price fluctuations.

Moreover, laboratories have accelerated localization efforts, investing in domestic production capabilities for critical reagents and exploring flexible sourcing strategies for consumables. This shift has prompted equipment vendors to reconsider their manufacturing footprints and offer bundled service agreements to help clients navigate incremental costs. While the cumulative effect of tariffs has created short-term budgetary pressures, it has also fostered greater collaboration between stakeholders to optimize value chains and reinforce supply chain resilience in an increasingly protectionist environment.

Uncovering Detailed Service Type, Technological, Application, and End User Segmentation Dynamics in Bioanalytical Testing

Market segmentation by service type reveals a layered ecosystem where assay specialization and methodological depth drive laboratory focus areas. Biomarker Analysis encompasses genetic biomarker assays, metabolite biomarker evaluations, and protein biomarker quantification, each delivering critical insights into pharmacodynamic responses. Delving into absorption, distribution, metabolism, and excretion, DMPK Services break down into in vitro ADME evaluations for early screening and in vivo ADME explorations for comprehensive pharmacokinetic profiling. Meanwhile, Genetic Toxicology employs classical Ames tests alongside chromosomal aberration and micronucleus assays to ascertain genotoxic risk profiles. Immunoassay Testing has expanded capability through enzyme-linked immunosorbent assays, multiplexed panels, and radioimmunoassays that deliver sensitivity and specificity. Pharmacokinetic Studies integrate these services to construct full pharmacokinetic curves across diverse matrices.

Turning to technological segmentation, gas chromatography-mass spectrometry platforms offer both chemical ionization and electron impact ionization modes for volatile analyte detection. High-performance liquid chromatography systems utilize ion exchange, reverse phase, and size exclusion columns to address complex sample matrices. Immunoassay platforms have evolved toward ELISA formats, multiplex assay workflows, and radioligand detection for scalable protein quantification. Liquid chromatography tandem mass spectrometry configurations leverage orbitrap accuracy, high-resolution time-of-flight channels, and robust triple quadrupole quantification. Nuclear magnetic resonance spectroscopy, with dedicated 13C and 1H detection methods, continues to provide non-destructive structural elucidation.

Within application domains, laboratories support biotechnology ventures seeking early-stage biomarker discovery, clinical diagnostics laboratories validating companion diagnostics, environmental testing sites monitoring trace contaminants, food and beverage testing units ensuring safety compliance, and pharmaceutical manufacturers characterizing novel drug entities. Finally, end users range from academic research institutes pursuing fundamental science, contract research organizations offering turnkey testing solutions, hospitals and clinics integrating bioanalysis into patient care workflows, to pharmaceutical and biotechnology companies driving therapeutic innovation.

Analyzing Key Drivers and Infrastructure Trends Across Americas, Europe Middle East Africa, and Asia Pacific in Bioanalytical Testing

Regional performance in bioanalytical testing services demonstrates distinct drivers and growth accelerators across the globe. In the Americas, robust biopharmaceutical pipelines in North America are complemented by emerging research hubs in Latin America, fostering demand for specialized assays and contract research solutions. Stakeholders in this region benefit from strong regulatory alignment and established distribution networks, although rising tariff pressures have spurred efforts to onshore critical reagent production.

Across Europe, the Middle East, and Africa, the landscape is shaped by harmonized regulatory frameworks, such as centralized European Medicines Agency guidelines, which support cross-border clinical study bioanalysis. Investment in state-of-the-art analytical platforms is prevalent in Western Europe, while the Middle East and Africa are witnessing rapid infrastructure development, often through public-private partnerships focused on healthcare diagnostics and environmental monitoring.

In Asia-Pacific, fast-growing pharmaceutical sectors in countries like India, China, and Japan are driving substantial lab capacity expansion. Government initiatives to bolster domestic manufacturing of reagents and instruments are gaining momentum, aimed at reducing import dependency. At the same time, collaborative research agreements between regional CROs and global biotech firms are proliferating, signaling a shift toward integrated, geographically diverse bioanalytical networks.

Reviewing Strategic Technology Investments and Collaboration Models of Leading Bioanalytical Testing Service Providers

Leading companies in bioanalytical testing services are differentiating through technology investments, strategic partnerships, and service diversification. Major contract research organizations have expanded in-house capabilities to include high-throughput mass spectrometry and multiplex immunoassays, enhancing their appeal to large pharmaceutical clients seeking end-to-end solutions. A subset of specialized laboratories has carved out niches in biomarker discovery for immuno-oncology programs, leveraging proprietary assay platforms to deliver unique insights.

On the vendor side, instrumentation manufacturers are forging alliances with software providers to offer integrated informatics suites that streamline data analysis and compliance reporting. Others are establishing regional centers of excellence to support localized method development and rapid deployment of new assay protocols. Partnerships between academic institutions and commercial labs are also on the rise, enabling co-development of novel bioanalytical techniques and fostering talent pipelines.

Actionable Strategies for Laboratory Digitalization Supply Chain Resilience and Collaborative Innovation in Bioanalytical Testing

To maintain a competitive advantage, industry leaders must embrace a multifaceted strategic approach. Prioritizing investment in digital infrastructure-such as AI-enabled data analytics and laboratory information management systems-will enhance throughput and data integrity. Building resilient supply chains through diversified sourcing agreements and local manufacturing partnerships can mitigate disruptions from tariff fluctuations and logistical delays.

Cultivating collaborative alliances with academia and niche technology developers will accelerate method innovation and facilitate access to emerging biomarkers. Additionally, strengthening talent acquisition and retention programs, including specialized training for assay development and regulatory compliance, will ensure service excellence. Finally, adopting sustainable laboratory practices, from reducing solvent waste to implementing energy-efficient instrumentation, can drive cost savings while aligning with corporate responsibility goals.

Outlining a Methodical Combination of Secondary Literature Review and Stakeholder Interviews Ensuring Robust Data Triangulation

This research integrates comprehensive secondary data analysis with primary insights gathered through interviews with laboratory directors, regulatory experts, and procurement managers. Publicly accessible scientific literature, peer-reviewed journals, and regulatory guidance documents formed the foundation of the desk research, providing context on technological advancements and compliance requirements.

Primary data collection involved structured discussions with stakeholders across service providers, instrument vendors, and end-user organizations, ensuring a multifaceted perspective. Data triangulation techniques were employed to validate findings, cross-referencing interview insights with published case studies and industry news. Quality checks at each stage of analysis guaranteed accuracy and reliability, while thematic coding of qualitative inputs enabled the identification of emerging patterns and strategic imperatives.

Concluding Synthesis on Technological Evolution Regulatory Complexity and Strategic Imperatives in Bioanalytical Testing

The bioanalytical testing services landscape is defined by rapid technological evolution, regulatory complexity, and shifting global supply chain dynamics. By examining service types, technological platforms, application segments, and end-user profiles, stakeholders gain a nuanced view of market drivers and operational challenges.

Regional variations underscore the importance of adaptive strategies that align with local manufacturing capabilities, regulatory environments, and research priorities. The cumulative impact of recent tariff changes further highlights the need for resilient sourcing and strategic partnerships. As companies navigate this intricate environment, embracing digital transformation, collaborative innovation, and sustainable practices will be essential to sustaining growth and delivering high-value bioanalytical insights.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Service Type
    • Biomarker Analysis
      • Genetic Biomarker
      • Metabolite Biomarker
      • Protein Biomarker
    • DMPK Services
      • In Vitro ADME
      • In Vivo ADME
    • Genetic Toxicology
      • Ames Test
      • Chromosomal Aberration Test
      • Micronucleus Test
    • Immunoassay Testing
    • Pharmacokinetic Studies
  • Technology
    • GC-MS
      • Chemical Ionization
      • Electron Impact
    • HPLC
      • Ion Exchange
      • Reverse Phase
      • Size Exclusion
    • Immunoassays
      • ELISA
      • Multiplex Assays
      • RIA
    • LC-MS/MS
      • Orbitrap
      • Quadrupole Time Of Flight
      • Triple Quadrupole
    • NMR
      • 13C NMR
      • 1H NMR
  • Application
    • Biotechnology
    • Clinical Diagnostics
    • Environmental Testing
    • Food And Beverage
    • Pharmaceutical
  • End User
    • Academic Research Institutes
    • Contract Research Organizations
    • Hospitals And Clinics
    • Pharma Biotechnology Companies
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Laboratory Corporation of America Holdings
  • IQVIA Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • SGS SA
  • WuXi AppTec Co., Ltd.
  • Syneos Health Inc.
  • ICON plc
  • Thermo Fisher Scientific Inc.
  • Pharmaceutical Product Development, LLC

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of artificial intelligence and machine learning enhances bioanalytical data interpretation and workflow efficiency
5.2. Surging demand for high throughput bioanalytical screening to support accelerated drug discovery timelines
5.3. Expansion of cell and gene therapy analytics driving need for specialized bioanalytical assays and platforms
5.4. Increasing adoption of dried blood spot and microsampling techniques for decentralized clinical trial bioanalysis
5.5. Rising focus on immunogenicity assessment and anti-drug antibody testing in biologics development pipelines
5.6. Regulatory convergence and evolving guidance from FDA EMA and ICH reshaping bioanalytical method validation standards
5.7. Growth of biosimilars market fueling comprehensive comparability studies and robust bioanalytical comparability testing
5.8. Development of multiplexed bioanalytical platforms for simultaneous quantification of biomarkers and drug metabolites
5.9. Cloud based LIMS and digital platform integration transforming bioanalytical sample management and data traceability
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bioanalytical Testing Services Market, by Service Type
8.1. Introduction
8.2. Biomarker Analysis
8.2.1. Genetic Biomarker
8.2.2. Metabolite Biomarker
8.2.3. Protein Biomarker
8.3. DMPK Services
8.3.1. In Vitro ADME
8.3.2. In Vivo ADME
8.4. Genetic Toxicology
8.4.1. Ames Test
8.4.2. Chromosomal Aberration Test
8.4.3. Micronucleus Test
8.5. Immunoassay Testing
8.6. Pharmacokinetic Studies
9. Bioanalytical Testing Services Market, by Technology
9.1. Introduction
9.2. GC-MS
9.2.1. Chemical Ionization
9.2.2. Electron Impact
9.3. HPLC
9.3.1. Ion Exchange
9.3.2. Reverse Phase
9.3.3. Size Exclusion
9.4. Immunoassays
9.4.1. ELISA
9.4.2. Multiplex Assays
9.4.3. RIA
9.5. LC-MS/MS
9.5.1. Orbitrap
9.5.2. Quadrupole Time Of Flight
9.5.3. Triple Quadrupole
9.6. NMR
9.6.1. 13C NMR
9.6.2. 1H NMR
10. Bioanalytical Testing Services Market, by Application
10.1. Introduction
10.2. Biotechnology
10.3. Clinical Diagnostics
10.4. Environmental Testing
10.5. Food And Beverage
10.6. Pharmaceutical
11. Bioanalytical Testing Services Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Contract Research Organizations
11.4. Hospitals And Clinics
11.5. Pharma Biotechnology Companies
12. Americas Bioanalytical Testing Services Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bioanalytical Testing Services Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bioanalytical Testing Services Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Laboratory Corporation of America Holdings
15.3.2. IQVIA Holdings Inc.
15.3.3. Charles River Laboratories International, Inc.
15.3.4. Eurofins Scientific SE
15.3.5. SGS SA
15.3.6. WuXi AppTec Co., Ltd.
15.3.7. Syneos Health Inc.
15.3.8. ICON plc
15.3.9. Thermo Fisher Scientific Inc.
15.3.10. Pharmaceutical Product Development, LLC
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BIOANALYTICAL TESTING SERVICES MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BIOANALYTICAL TESTING SERVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BIOANALYTICAL TESTING SERVICES MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BIOANALYTICAL TESTING SERVICES MARKET: RESEARCHAI
FIGURE 24. BIOANALYTICAL TESTING SERVICES MARKET: RESEARCHSTATISTICS
FIGURE 25. BIOANALYTICAL TESTING SERVICES MARKET: RESEARCHCONTACTS
FIGURE 26. BIOANALYTICAL TESTING SERVICES MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BIOANALYTICAL TESTING SERVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY METABOLITE BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY METABOLITE BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PROTEIN BIOMARKER, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PROTEIN BIOMARKER, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VITRO ADME, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VITRO ADME, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VIVO ADME, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IN VIVO ADME, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY AMES TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY AMES TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMOSOMAL ABERRATION TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHROMOSOMAL ABERRATION TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MICRONUCLEUS TEST, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MICRONUCLEUS TEST, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAY TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAY TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACOKINETIC STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHEMICAL IONIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CHEMICAL IONIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ELECTRON IMPACT, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ELECTRON IMPACT, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ION EXCHANGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ION EXCHANGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REVERSE PHASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY REVERSE PHASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SIZE EXCLUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SIZE EXCLUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MULTIPLEX ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY MULTIPLEX ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY RIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY RIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ORBITRAP, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ORBITRAP, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY QUADRUPOLE TIME OF FLIGHT, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY QUADRUPOLE TIME OF FLIGHT, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TRIPLE QUADRUPOLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TRIPLE QUADRUPOLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY 13C NMR, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY 13C NMR, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY 1H NMR, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY 1H NMR, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOTECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ENVIRONMENTAL TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMACEUTICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HOSPITALS AND CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMA BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY PHARMA BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2025-2030 (USD MILLION)
TABLE 131. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2018-2024 (USD MILLION)
TABLE 132. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2025-2030 (USD MILLION)
TABLE 157. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2018-2024 (USD MILLION)
TABLE 158. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2025-2030 (USD MILLION)
TABLE 159. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 164. UNITED STATES BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 165. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 166. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 167. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2018-2024 (USD MILLION)
TABLE 168. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2025-2030 (USD MILLION)
TABLE 169. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2018-2024 (USD MILLION)
TABLE 170. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2025-2030 (USD MILLION)
TABLE 171. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 172. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 173. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2018-2024 (USD MILLION)
TABLE 176. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2025-2030 (USD MILLION)
TABLE 177. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 178. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 179. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 180. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 181. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2018-2024 (USD MILLION)
TABLE 182. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2025-2030 (USD MILLION)
TABLE 183. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2018-2024 (USD MILLION)
TABLE 184. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2025-2030 (USD MILLION)
TABLE 185. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 186. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 187. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. CANADA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 191. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2018-2024 (USD MILLION)
TABLE 192. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2025-2030 (USD MILLION)
TABLE 193. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2018-2024 (USD MILLION)
TABLE 194. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2025-2030 (USD MILLION)
TABLE 195. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 196. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 197. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 202. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 203. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 205. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2018-2024 (USD MILLION)
TABLE 206. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2025-2030 (USD MILLION)
TABLE 207. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2018-2024 (USD MILLION)
TABLE 208. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2025-2030 (USD MILLION)
TABLE 209. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. MEXICO BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2025-2030 (USD MILLION)
TABLE 233. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 234. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 235. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 236. BRAZIL BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. ARGENTINA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY NMR, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY BIOMARKER ANALYSIS, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY DMPK SERVICES, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GENETIC TOXICOLOGY, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY GC-MS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY HPLC, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY IMMUNOASSAYS, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM BIOANALYTICAL TESTING SERVICES MARKET SIZE, BY LC-MS/MS, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM BIOANALYTICAL

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bioanalytical Testing Services market report include:
  • Laboratory Corporation of America Holdings
  • IQVIA Holdings Inc.
  • Charles River Laboratories International, Inc.
  • Eurofins Scientific SE
  • SGS SA
  • WuXi AppTec Co., Ltd.
  • Syneos Health Inc.
  • ICON plc
  • Thermo Fisher Scientific Inc.
  • Pharmaceutical Product Development, LLC

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.22 Billion
Forecasted Market Value ( USD ) by 2030 $ 8.25 Billion
Compound Annual Growth Rate9.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030 - Product Image

Bioanalytical Testing Services in CRO Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (Bioavailability, Bioequivalence), Test, Workflow, End-Use, and Region with Growth Forecasts, 2025-2030

  • Report
  • 180 Pages
  • Global
From
Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (ADME, PD), Workflow, Application, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Bioanalytical Testing Services Market Size, Share & Trends Analysis Report by Molecule (Small, Large), Test (ADME, PD), Workflow, Application, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 150 Pages
  • Global
From
Bioanalytical Testing Services Market Report by Molecule Type, Test Type, Workflow, and Region 2024-2032 - Product Image

Bioanalytical Testing Services Market Report by Molecule Type, Test Type, Workflow, and Region 2024-2032

  • Report
  • 140 Pages
  • Global
From
Large Molecule Bioanalytical Technologies - Global Strategic Business Report - Product Image

Large Molecule Bioanalytical Technologies - Global Strategic Business Report

  • Report
  • 283 Pages
  • Global
From
Bioanalytical Testing Services - Global Strategic Business Report - Product Image

Bioanalytical Testing Services - Global Strategic Business Report

  • Report
  • 373 Pages
  • Global
From

About the Bioanalytical Testing Services Market

Bioanalytical Testing Services are a type of biotechnology that focuses on the analysis of biological samples. These services are used to measure the concentration of drugs, metabolites, and other substances in biological samples such as blood, urine, and tissue. Bioanalytical Testing Services are used to assess the safety and efficacy of drugs, biologics, and medical devices. They are also used to monitor the levels of therapeutic drugs in patients, as well as to detect and quantify biomarkers for disease diagnosis and prognosis. Bioanalytical Testing Services are provided by a variety of companies, including Eurofins Scientific, LabCorp, and Charles River Laboratories. Other companies in the market include WuXi AppTec, PPD, and Covance. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.